Compare · WLFC vs ZBH
WLFC vs ZBH
Side-by-side comparison of Willis Lease Finance Corporation (WLFC) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- WLFC operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $25.25B, about 120.7x WLFC ($209.2M).
- Over the past year, WLFC is up 28.3% and ZBH is down 10.2% - WLFC leads by 38.6 points.
- WLFC has been more active in the news (4 items in the past 4 weeks vs 2 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 0 for WLFC).
- Company
- Willis Lease Finance Corporation
- Zimmer Biomet Holdings Inc.
- Price
- $190.83+1.03%
- $91.33-1.18%
- Market cap
- $209.2M
- $25.25B
- 1M return
- +8.32%
- +4.25%
- 1Y return
- +28.35%
- -10.23%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 1996
- News (4w)
- 4
- 2
- Recent ratings
- 0
- 25
Willis Lease Finance Corporation
Willis Lease Finance Corporation operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. The company operates through two segments, Leasing and Related Operations, and Spare Parts Sales. The Leasing and Related Operations segment engages in acquiring and leasing commercial aircraft, aircraft engines, and other aircraft equipment, as well as the purchase and resale of commercial aircraft engines and other aircraft equipment, and other related businesses. The Spare Parts Sales segment purchases and resells after-market engine parts, whole engines, engine modules, and portable aircraft components. Willis Lease Finance Corporation was founded in 1985 and is headquartered in Coconut Creek, Florida.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest WLFC
- SEC Form DEF 14A filed by Willis Lease Finance Corporation
- Willis Lease Finance Corporation Announces Timing of First Quarter 2026 Financial Results and Conference Call
- Willis Lease Finance Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Willis Lease Finance Corporation
- SEC Form 4 filed by Willis Charles F Iv
- SEC Form 4 filed by Willis Austin Chandler
- SEC Form 4 filed by Flaherty Scott B.
- SEC Form 4 filed by Willis Charles F Iv
- Willis Lease Finance Corporation Closes Two Additional JOLCO Deals, Bringing Total JOLCO Financing to Nearly $150 Million
- Willis Lease Finance Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Latest ZBH
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- SEC Form 4 filed by Noor Jehanzeb
- SEC Form 4 filed by Jafry Syed A.
- SEC Form 4 filed by Kolli Sreelakshmi
- SEC Form 4 filed by Shapiro Louis
- SEC Form 4 filed by Hilado Maria Teresa
- SEC Form 4 filed by Higgins Arthur J
- SEC Form 4 filed by Kurdikar Devdatt
- SEC Form 4 filed by Hagemann Robert